Search and analyze individual stocks with comprehensive metrics
Sudarshan Pharma
Fundamental Score
Sudarshan Pharma Share Price & Market Analysis
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of SUDARSHAN across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (15.51%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Robust Profit Growth (427.27%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (46.43%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (27.83% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (41.08% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (69.73% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Balanced Promoter Holding (57.39%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
5 factors identified
Margin Pressure Concerns (4.84%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Elevated Debt Levels (D/E: 1.30)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.
Negative Free Cash Flow (₹-12.20 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
📊 Educational Market Overview
Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.
Loading Peer Comparison
Finding companies in the Specialty Chemicals sector...
Financial Statements
Comprehensive financial data for Sudarshan Pharma
About SUDARSHAN
Company Details
Market Information
Performance
SUDARSHAN Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of SUDARSHAN?
SUDARSHAN is currently trading at ₹28.63 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of SUDARSHAN shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.
What is the P/E ratio of SUDARSHAN and what does it mean?
SUDARSHAN has a P/E ratio of 36.03x compared to the industry average of 33.84x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹36 for every ₹1 of annual earnings. This is higher than the industry average, suggesting either growth premium or potential overvaluation.
How is SUDARSHAN performing according to Bull Run's analysis?
SUDARSHAN has a Bull Run fundamental score of 61.3/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 14.83%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.
What sector and industry does SUDARSHAN belong to?
SUDARSHAN operates in the Chemicals & Petrochemicals industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Sudarshan Pharma. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.
What is Return on Equity (ROE) and why is it important for SUDARSHAN?
SUDARSHAN has an ROE of 14.83%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Sudarshan Pharma generates profits from shareholders' equity. An ROE of 15% means the company generates ₹15 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.
How is SUDARSHAN's debt-to-equity ratio and what does it indicate?
SUDARSHAN has a debt-to-equity ratio of 1.30, which indicates high leverage that increases financial risk. This means the company has ₹130 of debt for every ₹100 of equity. Higher leverage can amplify returns during good times but increases bankruptcy risk during downturns.
What is SUDARSHAN's dividend yield and is it a good dividend stock?
SUDARSHAN offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.
How has SUDARSHAN grown over the past 5 years?
SUDARSHAN has achieved 5-year growth rates of: Sales Growth 27.83%, Profit Growth 69.73%, and EPS Growth 41.08%. This consistent double-digit growth indicates a strong business model and competitive positioning. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.
What is the promoter holding in SUDARSHAN and why does it matter?
Promoters hold 57.39% of SUDARSHAN shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.
How does SUDARSHAN compare with its industry peers?
SUDARSHAN trades at P/E 36.03x vs industry average 33.84x, with ROE of 14.83% and ROCE of 15.51%. The stock trades at a premium to industry average, which may be justified by superior fundamentals. Peer comparison helps identify whether SUDARSHAN is outperforming its competitive set in profitability, growth, and valuation metrics.
What is SUDARSHAN's market capitalization and what category does it fall into?
SUDARSHAN has a market capitalization of ₹650 crores, making it a Large-cap stock. Large-cap stocks offer stability and liquidity but typically slower growth. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.
What are the key financial ratios to consider for SUDARSHAN?
Key ratios for SUDARSHAN: ROE 14.83% (Good), ROCE 15.51%, P/E 36.03x, Debt-to-Equity 1.30, Interest Coverage 2.55x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.
How volatile is SUDARSHAN stock and what is its beta?
SUDARSHAN has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.
What is the 52-week high and low for SUDARSHAN?
SUDARSHAN has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹28.63, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.
What are the key risks associated with investing in SUDARSHAN?
Key risks for SUDARSHAN include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 1.30), and operational challenges. The stock has a Fundamental Score of 61.3/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Chemicals & Petrochemicals include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.
What is SUDARSHAN's operating profit margin and how has it trended?
SUDARSHAN has a 5-year average Operating Profit Margin (OPM) of 4.84%, which suggests room for improvement in operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.
How is SUDARSHAN's quarterly performance in terms of sales and profit growth?
SUDARSHAN's recent quarterly performance shows YoY Sales Growth of 46.43% and YoY Profit Growth of 427.27%. This strong double-digit growth indicates excellent business momentum and management execution. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.
What is the FII and DII holding pattern in SUDARSHAN?
SUDARSHAN has FII holding of 19.49% and DII holding of 0.00%, totaling 19.49% institutional ownership. This institutional participation level shows the confidence of professional money managers. Significant FII holding suggests global investor confidence and potential for index inclusion. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.